Risk-Assessment-Based Optimization Favours the Development of Albumin Nanoparticles with Proper Characteristics Prior to Drug Loading

Albumin nanocarrier research and development is a challenging area in the field of personalized medicine and in providing advanced therapeutic solutions. Albumin as a biocompatible, nonimmunogenic, and non-toxic protein carrier that can be exploited to conjugate drugs with poor bioavailability to im...

Descripción completa

Detalles Bibliográficos
Autores principales: Katona, Gábor, Sipos, Bence, Csóka, Ildikó
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611155/
https://www.ncbi.nlm.nih.gov/pubmed/36297472
http://dx.doi.org/10.3390/pharmaceutics14102036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611155/
https://www.ncbi.nlm.nih.gov/pubmed/36297472
http://dx.doi.org/10.3390/pharmaceutics14102036

Ejemplares similares